companydata.dkHEI Therapeutics ApS: Financial statements 2023
CVR: 42613207
HEI Therapeutics ApS (CVR 42613207) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK 3,935,885 and a net result of DKK -381,736. Equity amounted to DKK -626,153. The company had 5 employees in the financial year.
- Gross Profit
- 3,935,885 kr.
- Profit/Loss
- -381,736 kr.
- Equity
- -626,153 kr.
- Total Assets
- 20,999,187 kr.
- Employees
- 5
Events in 2023
HEI Therapeutics ApS has published its interim report for the period August 20, 2021 – December 31, 2022.
About HEI Therapeutics ApS
HEI Therapeutics ApS was a Danish company of the type Anpartsselskab based in København N, founded in 2021. The company was registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Kenneth Berg. The company is owned by HOGDALL HOLDING ApS, WISV Holding ApS and JKimer Holding ApS. In 2024, the company reported a gross profit of DKK 1,762,455 and a net result of DKK -12,890,414 compared with DKK -381,736 the year before. Equity amounted to DKK -13,516,567.